title: Second malignancy risk in prostate cancer and radiotherapy.
authors.affiliation: Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
authors.forename: Tomer
authors.initials: T
authors.lastname: Charas
authors.affiliation: Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
authors.forename: Amandeep
authors.initials: A
authors.lastname: Taggar
authors.affiliation: Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Zelefsky
mesh_terms: D004249:DNA Damage / Q000528:radiation effects; D020022:Genetic Predisposition to Disease; D006801:Humans; D008297:Male; D016609:Neoplasms, Second Primary / Q000453:epidemiology / Q000209:etiology*; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011878:Radiotherapy / Q000009:adverse effects / Q000379:methods; D012306:Risk
keywords: prostate cancer; radiation; secondary malignancy